Mark Copley, technical sales manager for Copley Scientific, will lead an interactive workshop on 'Process improvements and troubleshooting for cascade impactor testing' at RDD Europe 2007 in Paris
The focus of the session will be practical methods for increasing productivity and reducing variability - key issues for impactor testing within the pharmaceutical industry.
Copley Scientific says it is recognised as the world's leading manufacturer of inhaler test equipment, with extensive experience in the application and use of cascade impactors.
Workshop numbers are limited and demand is expected to be high following the success of Copley's presentation at RDD Europe 2005.
The rapid pace of development of inhalers; topical, systemic and generic, is intensifying pressure on testing processes.
This workshop will present ways to improve testing efficiency.
The focus will be on pharmacopeial methodologies and the use of both the Andersen cascade and Next Generation Pharmaceutical impactors, in combination with test systems for aerodynamic particle size analysis.
It will be valuable for both R+D and QC personnel involved with the in vitro testing of metered dose and dry powder inhalers, nebulisers and nasal sprays.
RDD Europe 2007 is a significant conference for respiratory drug delivery researchers, offering the community an opportunity to discuss new research methods and view the latest advances in industry-related equipment.
Copley Scientific will be exhibiting throughout the event.
